SBIR [Phase II]: Development of Percutaneous DLC for Total Cavo-pulmonary Assistance

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/177/31/17

Funding

  • W-Z Biotech LLC: $117,831.00